Alzheimer’s disease is the most common cause of dementia in the UK. It’s progressive condition, meaning symptoms develop gradually over many years, eventually becoming more severe. It affects multiple brain functions, but one of the first symptoms, according to NHS doctor, Dr James O’Donovan, is memory lapses. Having amassed more than 25,000 followers on TikTok, … Read more
WASHINGTON — Scientists have found a way to help Alzheimer’s drugs seep inside the brain faster — by temporarily breaching its protective shield. The novel experiment was a first attempt in just three patients. But in spots in the brain where the new technology took aim, it enhanced removal of Alzheimer’s trademark brain-clogging plaque, researchers … Read more
NEW YORK — Drugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that has developed a new antipsychotic, in a $14 billion deal. Bristol Myers Squibb and Karuna announced their merger agreement on Friday. The transaction, which amounts to $330 per share in cash, offers a premium of 53% over Karuna’s stock on … Read more
